CD36 and atherosclerosis: Loss of Ash2l abundance at the promoter of PPARγ inhibited CD36 transcription, which significantly weakened the proximity ligation signals between TLR4 and CD36, thus reducing NF-κB signal activation and contributing to the protection against endothelial injury and atherosclerosis.